Investigator Development Core
研究者开发核心
基本信息
- 批准号:10657711
- 负责人:
- 金额:$ 58.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-24 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAffectAfrican American populationApplications GrantsArkansasAwardBlack raceCardiovascular DiseasesChronic DiseaseCommunitiesCompetenceConsultDataDevelopmentDisparityDisparity populationDiverse WorkforceEquityEthnic PopulationEvaluationFundingGoalsGrantGrant ReviewGrant Review ProcessHealthHealth Disparities ResearchHealth PolicyHealth PromotionHistorically Black Colleges and UniversitiesHuman RightsImprove AccessIndividualInequityInfrastructureInstitutionInstitutional PolicyInterventionLinkMalignant NeoplasmsMedicalMentorsMethodsModelingMonitorMorbidity - disease rateNational Institute on Minority Health and Health DisparitiesPerformancePilot ProjectsProcessProcess AssessmentProductivityRaceReadinessReduce health disparitiesResearchResearch PersonnelResearch Project GrantsRisk FactorsRuralScienceSecureSocial JusticeStrategic PlanningStructureSupport GroupsSystemTrainingTraining ProgramsUnderrepresented PopulationsUnited StatesUnited States National Institutes of HealthUniversitiesWomanWorkWorkforce DevelopmentWritingcancer health disparitycardiovascular disorder riskcareercareer developmentcohortcollegecommunity engagementcommunity partnershipconcept mappingcultural equitydesigndisease disparitydiversity and inclusionethnic disparityevidence basehealth care availabilityhealth disparityhealth equityinnovationlensmembermortalitynetwork modelsnovelprogramsracial disparityracial populationrecruitresearch studyresponseskillssocialsocial disparitiessocial structurestructural determinantssuccesstraining opportunity
项目摘要
PROJECT SUMMARY – INVESTIGATOR DEVELOPMENT CORE
Eliminating health disparities in Arkansas is particularly challenging, since rural and Black/African American
populations are disproportionately affected by the burden of chronic disease. As part of strategic plans to
address the problem, a diverse and productive workforce is needed to conduct research that mitigates health
disparities and supports health equity. Supporting early stage investigators provides an effective and productive
solution in workforce development, when structured plans are provided for investigators who come from health
disparity and underrepresented groups. The overarching goal of the Investigator Development Core is to reduce
inequities in the number of historically underrepresented researchers prepared to eliminate cancer and
cardiovascular disease health disparities by building a strong evidence-based training and mentoring
infrastructure that enhances skills and competencies of investigators to successfully compete for pilot project
funding, and subsequently secure National Institutes of Health research grants. The Core will apply social justice
principles and the National Institute on Minority Health and Health Disparities Research Framework to address
individual, interpersonal, and institutional structural factors that influence the diversity in the research workforce,
underrepresented researcher access to grant awards, equity in training and mentoring, participation in research
with community partners, and ultimately, increase the number of research studies that focus on eliminating
chronic disease disparities among groups often denied the human right to health. The Investigator Development
Core will use a mixed-methods approach (concept mapping, individual assessments pre-application) to capture
relevant data to assist the team in developing relevant training and mentoring components pre/post award. The
community liaison for the Training Mentoring Advisory Board will review grants for their impact on health equity
prior to submission and work with the Community Engagement Core to link community partners and pilot study
investigators. Finally, the Investigator Development Core will build on the National Mentoring Research Network
model to increase participation in the pilot grant program by addressing inequities in readiness to submit research
grants, using one-on-one consults, providing grant coaching and writing group support, and conducting team-
oriented mentoring to guide investigators from idea conceptualization to subsequent submission of an NIH grant
application. The expected impact will be increased recruitment, retention and professional advancement of early
stage investigators in conducting chronic disease health disparities research that informs future research, health
policy, and programmatic responses to eliminate health disparities.
项目总结——调查员发展核心
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark L Williams其他文献
Mark L Williams的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark L Williams', 18)}}的其他基金
Tanzanian Drug Treatment as AIDS Prevention - Reliability and Validity Study
坦桑尼亚药物治疗作为艾滋病预防 - 可靠性和有效性研究
- 批准号:
8300392 - 财政年份:2009
- 资助金额:
$ 58.92万 - 项目类别:
Tanzanian Drug Treatment as AIDS Prevention - Reliability and Validity Study
坦桑尼亚药物治疗作为艾滋病预防 - 可靠性和有效性研究
- 批准号:
7756281 - 财政年份:2009
- 资助金额:
$ 58.92万 - 项目类别:
EFFECT OF UREMIC GLUCOSE INTOLERANCE ON AGE'S & AGE LEVELS W/ VASCULAR DISEASE
尿毒症葡萄糖不耐受对年龄的影响
- 批准号:
7205223 - 财政年份:2005
- 资助金额:
$ 58.92万 - 项目类别:
Tanzania Injection Drug Use/HIV Prevention Project
坦桑尼亚注射吸毒/艾滋病毒预防项目
- 批准号:
7022979 - 财政年份:2005
- 资助金额:
$ 58.92万 - 项目类别:
Tanzania Injection Drug Use/HIV Prevention Project
坦桑尼亚注射吸毒/艾滋病毒预防项目
- 批准号:
6892578 - 财政年份:2005
- 资助金额:
$ 58.92万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 58.92万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 58.92万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 58.92万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 58.92万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 58.92万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 58.92万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 58.92万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 58.92万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 58.92万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 58.92万 - 项目类别:
Research Grant